Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
Int J Mol Sci ; 21(21)2020 Oct 24.
Article in English | MEDLINE | ID: mdl-33114430

ABSTRACT

Dietary supplementation with polyunsaturated fatty acids (PUFA) n-3 can affect cutaneous wound healing; however, recent findings demonstrate the variable extent of their influence on the quality of healing. Here, we compare the effect of several dietary oils, containing different levels of PUFA n-3 and PUFA n-6, on wound healing in the rat model. Rats were fed the feed mixture with 8% palm oil (P), safflower oil (S), fish oil (F) or Schizochytrium microalga extract (Sch) and compared to the animals fed by control feed mixture (C). Dorsal full-thickness cutaneous excisions were performed after 52 days of feeding and skin was left to heal for an additional 12 days. Histopathological analysis of skin wounds was performed, including immune cells immunolabeling and the determination of hydroxyproline amount as well as gene expression analyses of molecules contributing to different steps of the healing. Matrix-assisted-laser-desorption-ionization mass-spectrometry-imaging (MALDI-MSI) was used to determine the amount of collagen α-1(III) chain fragment in healing samples. Treatment by Schizochytrium extract resulted in decrease in the total wound area, in contrast to the safflower oil group where the size of the wound was larger when comparing to control animals. Diet with Schizochytrium extract and safflower oils displayed a tendency to increase the number of new vessels. The number of MPO-positive cells was diminished following any of oil treatment in comparison to the control, but their highest amount was found in animals with a fish oil diet. On the other hand, the number of CD68-positive macrophages was increased, with the most significant enhancement in the fish oil and safflower oil group. Hydroxyproline concentration was the highest in the safflower oil group but it was also enhanced in all other analyzed treatments in comparison to the control. MALDI-MSI signal intensity of a collagen III fragment decreased in the sequence C > S > Sch > P > F treatment. In conclusion, we observed differences in tissue response during healing between dietary oils, with the activation of inflammation observed following the treatment with oil containing high eicosapentaenoic acid (EPA) level (fish oil) and enhanced healing features were induced by the diet with high content of docosahexaenoic acid (DHA, Schizochytrium extract).


Subject(s)
Dietary Fats, Unsaturated/administration & dosage , Fatty Acids, Omega-3/analysis , Fatty Acids, Omega-6/analysis , Skin/injuries , Wound Healing/drug effects , Animals , CD8 Antigens/metabolism , Collagen Type III/metabolism , Dietary Fats, Unsaturated/pharmacology , Disease Models, Animal , Fish Oils/administration & dosage , Fish Oils/chemistry , Fish Oils/pharmacology , Indoles/chemistry , Macrophages/immunology , Male , Palm Oil/administration & dosage , Palm Oil/chemistry , Palm Oil/pharmacology , Rats , Safflower Oil/administration & dosage , Safflower Oil/chemistry , Safflower Oil/pharmacology , Skin/drug effects , Skin/metabolism , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
2.
Sci Rep ; 9(1): 1660, 2019 02 07.
Article in English | MEDLINE | ID: mdl-30733487

ABSTRACT

We focused on the biomechanical and morphological characteristics of prostate cancer cells and their changes resulting from the effect of docetaxel, cisplatin, and long-term zinc supplementation. Cell population surviving the treatment was characterized as follows: cell stiffness was assessed by atomic force microscopy, cell motility and invasion capacity were determined by colony forming assay, wound healing assay, coherence-controlled holographic microscopy, and real-time cell analysis. Cells of metastatic origin exhibited lower height than cells derived from the primary tumour. Cell dry mass and CAV1 gene expression followed similar trends as cell stiffness. Docetaxel- and cisplatin-surviving cells had higher stiffness, and decreased motility and invasive potential as compared to non-treated cells. This effect was not observed in zinc(II)-treated cells. We presume that cell stiffness changes may represent an important overlooked effect of cisplatin-based anti-cancer drugs. Atomic force microscopy and confocal microscopy data images used in our study are available for download in the Zenodo repository ( https://zenodo.org/ , Digital Object Identifiers:10.5281/zenodo.1494935).


Subject(s)
Actins/metabolism , Antineoplastic Agents/pharmacology , Cell Proliferation , Cisplatin/pharmacology , Mechanotransduction, Cellular , Prostatic Neoplasms/drug therapy , Humans , Male , Neoplasm Invasiveness , Prostatic Neoplasms/pathology , Tumor Cells, Cultured , Wound Healing
3.
PLoS One ; 11(11): e0165830, 2016.
Article in English | MEDLINE | ID: mdl-27824899

ABSTRACT

The effects of sarcosine on the processes driving prostate cancer (PCa) development remain still unclear. Herein, we show that a supplementation of metastatic PCa cells (androgen independent PC-3 and androgen dependent LNCaP) with sarcosine stimulates cells proliferation in vitro. Similar stimulatory effects were observed also in PCa murine xenografts, in which sarcosine treatment induced a tumor growth and significantly reduced weight of treated mice (p < 0.05). Determination of sarcosine metabolism-related amino acids and enzymes within tumor mass revealed significantly increased glycine, serine and sarcosine concentrations after treatment accompanied with the increased amount of sarcosine dehydrogenase. In both tumor types, dimethylglycine and glycine-N-methyltransferase were affected slightly, only. To identify the effects of sarcosine treatment on the expression of genes involved in any aspect of cancer development, we further investigated expression profiles of excised tumors using cDNA electrochemical microarray followed by validation using the semi-quantitative PCR. We found 25 differentially expressed genes in PC-3, 32 in LNCaP tumors and 18 overlapping genes. Bioinformatical processing revealed strong sarcosine-related induction of genes involved particularly in a cell cycle progression. Our exploratory study demonstrates that sarcosine stimulates PCa metastatic cells irrespectively of androgen dependence. Overall, the obtained data provides valuable information towards understanding the role of sarcosine in PCa progression and adds another piece of puzzle into a picture of sarcosine oncometabolic potential.


Subject(s)
Cell Cycle/drug effects , Gene Expression Regulation, Neoplastic/drug effects , Genes, Neoplasm/physiology , Prostatic Neoplasms/metabolism , Sarcosine/pharmacology , Animals , Cell Cycle/physiology , Cell Line, Tumor , Gene Expression Regulation, Neoplastic/physiology , Glycine N-Methyltransferase/metabolism , Humans , Male , Mice , Mice, Inbred BALB C , Mice, Nude , Neoplasm Transplantation , Polymerase Chain Reaction , Prostatic Neoplasms/physiopathology , Sarcosine/metabolism , Sarcosine Dehydrogenase/metabolism , Transcriptome , Up-Regulation
4.
Prostate ; 76(7): 679-90, 2016 May.
Article in English | MEDLINE | ID: mdl-26847870

ABSTRACT

BACKGROUND: Sarcosine (N-methylglycine) was previously delineated as a substantial oncometabolite of prostate cancer (PCa) and its metabolism seems to be significantly involved in PCa development and behavior. METHODS: We focused on investigation whether the exposure of prostate cells (PNT1A, 22Rv1, and PC-3) to sarcosine-related amino acids (glycine, dimethylglycine, and sarcosine) affects their aggressiveness (cell mobility and division rates, using real-time cell based assay). The effect of supplementation on expression of glycine-N-methyltransferase (GNMT) mRNA was examined using qRT-PCR. Finally, post-treatment amino acids patterns were determined with consequent statistical processing using the Ward's method, factorial ANOVA and principal component analysis (P < 0.05). RESULTS: The highest migration induced sarcosine and glycine in metastatic PC-3 cells (a decrease in relative free area about 53% and 73%). The highest cell division was achieved after treatment of 22Rv1 and PC-3 cells with sarcosine (time required for division decreased by 65% or 45%, when compared to untreated cells). qRT-PCR revealed also significant effects on expression of GNMT. Finally, amino acid profiling shown specific amino acid patterns for each cell line. In both, treated and untreated PC-3 cells significantly higher levels of serine, glutamic acid, and aspartate, linked with prostate cancer progression were found. CONCLUSIONS: Sarcosine-related amino acids can exceptionally affect the behavior of benign and malignant prostate cells.


Subject(s)
Amino Acids/pharmacology , Prostate/metabolism , Prostatic Neoplasms/metabolism , Sarcosine/metabolism , Cell Line , Cell Line, Tumor , Cell Movement/drug effects , Glycine N-Methyltransferase/genetics , Glycine N-Methyltransferase/metabolism , Humans , Male , Prostate/drug effects , Prostate/pathology , Prostatic Neoplasms/pathology
5.
Tohoku J Exp Med ; 236(3): 199-207, 2015 07.
Article in English | MEDLINE | ID: mdl-26094568

ABSTRACT

Haloperidol is a neuroleptic drug used for a medication of various psychoses and deliria. Its administration is frequently accompanied by cardiovascular side effects, expressed as QT interval prolongation and occurrence of even lethal arrhythmias. Despite these side effects, haloperidol is still prescribed in Europe in clinical practice. Haloperidol binds to sigma receptors that are coupled with inositol 1,4,5-trisphosphate (IP3) receptors. Sigma receptors are expressed in various tissues, including heart muscle, and they modulate potassium channels. Together with IP3 receptors, sigma receptors are also involved in calcium handling in various tissues. Therefore, the present work aimed to study the effects of long-term haloperidol administration on the cardiac function. Haloperidol (2 mg/kg once a day) or vehiculum was administered by intraperitoneal injection to guinea pigs for 21 consecutive days. We measured the responsiveness of the hearts isolated from the haloperidol-treated animals to additional application of haloperidol. Expression of the sigma 1 receptor and IP3 receptors was studied by real time-PCR and immunohistochemical analyses. Haloperidol treatment caused the significant decrease in the relative heart rate and the prolongation of QT interval of the isolated hearts from the haloperidol-treated animals, compared to the hearts isolated from control animals. The expression of sigma 1 and IP3 type 1 and type 2 receptors was increased in both atria of the haloperidol-treated animals but not in ventricles. The modulation of sigma 1 and IP3 receptors may lead to altered calcium handling in cardiomyocytes and thus contribute to changed sensitivity of cardiac cells to arrhythmias.


Subject(s)
Gene Expression Regulation/drug effects , Haloperidol/pharmacology , Heart Ventricles/drug effects , Heart/physiology , Inositol 1,4,5-Trisphosphate Receptors/metabolism , Myocardium/metabolism , Receptors, sigma/metabolism , Animals , DNA, Complementary/genetics , Guinea Pigs , Haloperidol/adverse effects , Immunohistochemistry , Real-Time Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction , Sigma-1 Receptor
SELECTION OF CITATIONS
SEARCH DETAIL